Deep Breath Intelligence

Deep Breath Intelligence is an AI and mass spectrometry-based platform designed for non-invasive breath analysis in clinical care. They are developing a real-time breath analysis solution for metabolic profiling, chronic obstructive pulmonary disease, obstructive sleep apnea, epilepsy, sports performance, and sleep-associated metabolism.

Deep Breath Intelligence (DBI) is a MedTech company that leverages machine learning algorithms to unleash the potential of exhaled breath analysis. Their core offering is non-invasive solutions for early disease diagnosis and therapeutic drug monitoring, enabling precision medicine for better treatment outcomes. DBI's flagship product, DBI-EPIbreath, is a CE-marked device under IVDD that provides real-time measurement of total and free concentrations of the antiseizure medication valproic acid from a breath sample, delivering results within 10 minutes. This revolutionary technology addresses limitations of standard therapeutic drug monitoring approaches based on invasive blood sampling, which can take several days to provide results.

Deep Breath Intelligence Teams with HTEC Group and Effectum Medical to Accelerate the Launch of CE-marked Device under IVDD

deep breath intelligence

Unlocking the potential of olfaction through technology

Smell Tech

Deep Breath Intelligence Teams with HTEC Group and Effectum Medical to Accelerate the Launch of CE-marked device under IVDD

HTEC

To help them achieve greater speed in meeting both software and documentation requirements to ensure IVDD compliance of their medical software, DBI-EPIbreath®

Companies engaged in and developing platforms and tools for odor detection and measurements as well as provide insights and analytics for health industry applications such as disease detection.

Deep Breath Intelligence (DBI) is a MedTech company that leverages machine learning algorithms to unleash the potential of exhaled breath analysis. Their core offering is non-invasive solutions for early disease diagnosis and therapeutic drug monitoring, enabling precision medicine for better treatment outcomes. DBI's flagship product, DBI-EPIbreath, is a CE-marked device under IVDD that provides real-time measurement of total and free concentrations of the antiseizure medication valproic acid from a breath sample, delivering results within 10 minutes. This revolutionary technology addresses limitations of standard therapeutic drug monitoring approaches based on invasive blood sampling, which can take several days to provide results.
DBI-EPIbreath is a game-changer in epilepsy management, allowing reliable estimates of circulating valproic acid levels to aid patient management and enable quick medication decisions for seizure control. With a single breath sample, DBI-EPIbreath can test for multiple conditions, aligning with the company's vision of developing a broad range of products across different disease areas to drive precision medicine and improve people's health outcomes. In May 2023, DBI partnered with HTEC Group and Effectum Medical to accelerate the launch of DBI-EPIbreath and meet regulatory requirements, successfully achieving compliance in a record time of six months.

OW Smell Digital is a technology company focused on digitizing the human sense of smell for various applications. Founded in 2019 by scientists Emanuela Maggioni and Marianna Obrist as a spinout from the University of Sussex and UCL, the company aims to revolutionize human-computer interaction by incorporating olfactory experiences.
OW Smell Digital's key offerings include a digitally controlled multi-channel Scent Delivery Device and an adaptive, AI-powered, cloud-based software platform. The hardware device has up to 24 individual odor channels, while the software leverages AI to predict the perceptual and behavioral effects of different scents on users. This twin system allows for precise control and delivery of scents to enhance sensory experiences.
The company's technology has applications across multiple domains, including healthcare research, immersive experiences, and innovative research. In healthcare, OW Smell Digital is collaborating with Rockefeller University to create a standardized smell-test toolkit for measuring olfactory capabilities. Additionally, it is working with UCL on SmellHealth, a project focused on developing affordable smell-delivery technologies and smell training tools.
In the realm of immersive experiences, OW Smell Digital has partnered with companies like British Airways, New Reality Co, and Picture This Productions to deliver multisensory virtual and augmented reality experiences. The company's work on the VR 'FLY' experience earned the 2020 Lumiere Award for Best VR Edutainment.
OW Smell Digital has raised GBP 1 million in seed funding led by Parkwalk Advisors in March 2022, which will be used to expand the team and further develop its hardware and software products.

OW Smell digital

OVR Technology has developed various products and platforms to deliver scents synchronized with virtual and augmented reality content. Their flagship offering is the ION 3, a wearable scent technology device that can produce thousands of unique scent combinations. The ION three cartridges containing specific scents are designed to be attached to VR/AR headsets, allowing users to experience multisensory content via mobile, desktop, AR, and VR applications.
The company has also created the INHALE three Wellness Platform, which provides immersive virtual nature experiences coupled with precisely timed scent releases. This platform includes features like scent mood orbs, new scents like waterfall and mountaintop, and optional mood-specific meditation tracks. The INHALE products are designed to promote relaxation, reduce stress, increase calm and focus, and support mental well-being.
OVR Technology manufactures its scents in-house at its laboratory in Burlington. The company has developed a wide range of scents, including pleasant aromas like lavender and rose, as well as more pungent odors like garbage and gunpowder for specialized training simulations.
In January 2023, OVR Technology showcased the ION three at CES 2023, highlighting its potential applications for enhancing immersion in the metaverse. The company's technology has been recognized with awards, including the AUREA Award for Excellence in Impact in 2022 and the 'Best In Show: VR' award at AWE US 2022.

OVR Technology

Aryballe Technologies is a French startup founded in 2014 that develops digital olfactory technology combining biochemistry, advanced optics, and machine learning to mimic the human sense of smell. Their core offering is the NeOse product line, a portable "digital nose" capable of detecting and identifying hundreds of odors by capturing odor signatures through biochemical nanosensors and advanced optics. This data is then analyzed by software solutions, helping users make informed decisions across various applications like quality control, R&D, manufacturing, and end-user experiences.
The NeOse technology works by using an optical microarray with 64 biochemical nanosensors (peptides) that capture volatile odorant molecules. The interference between a light source and the sensor-odor complexes is measured by photodetectors, generating unique visual imprints for each odor. Machine learning algorithms then identify these imprints by comparing them against an olfactory database. As of 2022, Aryballe had identified over 50 potential applications across industries like food and beverage, automotive, household appliances, healthcare, and environmental monitoring.
Aryballe's digital nose offers an objective, portable, and cost-effective alternative to traditional gas chromatography methods for odor analysis. The company's NeOse Advance product, launched in 2022, utilizes silicon photonics for improved performance. Aryballe aims to bring its technology to consumer markets eventually, enabling applications like automatically stopping ovens when food is cooked or activating range hoods before odors spread.

Aryballe Technologies

Olorama is a company that specializes in scent marketing technology. Their flagship product is a patented scent generator or smell synthesizer that can electronically release ultra-realistic scents at the desired moment and maintain them in the environment for a configurable duration. This technology aims to stimulate the sense of smell to influence customer behavior, reinforce brand identity, and enhance the overall experience.
Olorama's scent generators support up to 10 different scents simultaneously, with an extensive library of over 200 scent options, ranging from chocolate and coffee to natural scents like rain and forest. The scent generators do not rely on heating, ensuring that the scents remain pure and authentic without any quality loss.
The company's scent generators boast the fastest scent diffusion speed on the market, achieved through a powerful yet silent fan system. This rapid diffusion capability allows for precise timing and control over the olfactory experience.
Olorama's technology offers multiple control options, including voice control via iOS app, API integration, custom scent emission software synchronized with videos, and DMX control. This versatility enables seamless integration into various applications and environments.

Olorama Tecnology

Inhalio is a global leader in digital scent systems that enable corporations to deploy scent experiences across various markets through its Digital Scent 3.0 Platform. The company's technology utilizes a data-centric process involving precise scent infusion, molecular dry-air diffusion, and detailed customer insights. Inhalio's platform encompasses infusion techniques that ensure fragrance purity and longevity, multi-scent dry-air diffusers with cartridge authentication, user-friendly mobile apps, and cloud-based monitoring and data analytics.
Inhalio's offerings encompass a range of scent cartridges tailored for specific purposes. These include mood-mapped scents designed to promote calmness, invigoration, or alertness, air-sanitizing cartridges that eliminate airborne pathogens, odor elimination cartridges, and motion sickness relief cartridges. A notable application of Inhalio's technology is the NOMAD SD3, a sophisticated in-vehicle scent diffuser that fits into cup holders, allowing drivers and passengers to select desired fragrances via a mobile app.
Inhalio's digital scent platform finds applications in various sectors, including automotive (enhancing in-vehicle experiences for OEMs and rideshare services), connected homes (delivering fine fragrances), retail (enabling fragrance sampling and ambiance enhancement), and hospitality (deploying purpose-built scents in hotels and senior care facilities). In January 2022, Inhalio partnered with Lumileds, granting the latter exclusive rights to manufacture and distribute the NOMAD SD3 diffuser to automotive customers worldwide.
In January 2020, Inhalio merged with Exhalia, another digital scent company, to meet the growing demand across multiple markets. This merger combined the expertise and patented technologies of both companies, creating a comprehensive digital scent platform for mass-market distribution.

Inhalió

Companies engaged in developing scent diffusion systems

Companies engaged in developing platforms and tools for odor detection and measurement as well as provide insights and analytics for commercial sectors such as chemical, food & beverage, environment, and production.

Companies engaged in developing platforms, experiences, and wearable tech aimed at providing the customer a more involved and immersive experience, companies involved in scent marketing and scent branding as well as systems that specifically target virtual and augmented reality (eg. Metaverse) applications

Companies engaged in developing scents and infusions

Most companies in this hub deals with creating/delivering bespoke aromas for businesses

Deep Breath Intelligence

Sources

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless